Drummond warns Rubio of national security risk in pharmaceutical supply chain – KOKH

Drummond warns Rubio of national security risk in pharmaceutical supply chain  KOKH

Oklahoma Attorney General Gentner Drummond says he is alerting Secretary of State Marco Rubio to a national security risk to the pharmaceutical supply chain. The AG joined 19 other state attorneys general in sending a letter to Secretary Rubio identifying what they say are national security risks. The attorneys general said Chinese businesses are exploiting the nation's pharmaceutical supply chain and warned of risks from pharmaceutical ingredients used in GLP-1 drugs, including semaglutide and tirzepatide. The AG said in one instance, a business in China exploiting gaps in oversight had direct ties to fentanyl manufacturers. “Chinese businesses have found and exploited a gap in the system that gives them a direct line to patients in the U.S.

who use popular injectable prescription drugs,” Drummond said. “This exploitation not only poses risks to the health and safety of consumers, but it constitutes a national security risk.” The coalition is asking Secretary Rubio to pursue greater oversight of the Green List program or stop "potentially deadly ingredients" from entering the country. "In September 2025, the Food and Drug Administration (FDA) authorized the creation of a Green List of suppliers, which has effectively given Chinese suppliers the ability to ship unapproved, knock-off products to the United States without detention or inspection," Drummond said in a press release. "As the letter states, despite efforts